NUVISAN The Science CRO

NUVISAN The Science CRO is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) founded in 1989 in Germany. With over 40 years of experience, the company offers tailored integrated solutions along the drug discovery and development value chain. NUVISAN was acquired by ALS Limited on April 1, 2024, becoming the most advanced drug discovery and development organization. NUVISAN provides a portfolio of services including Target Identification and Validation, Target-to-Lead, Lead-to-Candidate, Preclinical, and Clinical, which can be customized to specific projects. As a leader in the Health and Wellness and Pharmaceutical industries, NUVISAN is well-equipped to bring the next generation of medicines to market. To learn more about NUVISAN's unique and high-quality integrated solutions, visit www.nuvisan.com or send an email to [email protected].